Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ellerby

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Brain : a Journal of Neurology|January 24, 2026
Targeting UCHL3 attenuates pathological markers in neuronal models of Huntington's diseaseHasan Ishtayeh, Elena Battistoni, Sharon Pochtar, et al.
Journal of Neuroinflammation|March 8, 2024
TYROBP/DAP12 knockout in Huntington's disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deteriorationJordi Creus-Muncunill, Jean Vianney Haure-Mirande, Daniele Mattei, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 1996
Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the proteinT J Lyons, H Liu, J J Goto, et al.
Chemical Biology & Drug Design|August 3, 2006
Structural evaluation of a novel pro-apoptotic peptide coupled to CNGRC tumor homing sequence by NMRCristina M Sandoval, Bernhard H Geierstanger, Satoshi Fujimura, et al.
Neuron|July 31, 2010
Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's diseaseJohn P Miller, Jennifer Holcomb, Ismael Al-Ramahi, et al.
The Journal of Biological Chemistry|May 31, 2015
Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in VivoRobert O'Brien, Francesco DeGiacomo, Jennifer Holcomb, et al.
The Journal of Biological Chemistry|January 21, 2010
Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington diseaseChristian Landles, Kirupa Sathasivam, Andreas Weiss, et al.
Stem Cell Reports|December 15, 2015
Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem CellsKaren L Ring, Mahru C An, Ningzhe Zhang, et al.
Stem Cells (Dayton, Ohio)|May 8, 2025
Cerulenin Partially Corrects the Disrupted Developmental Transcriptomic Signature in Huntington's Disease Striatal Medium Spiny NeuronsCarlos Galicia Aguirre, Kizito-Tshitoko Tshilenge, Elena Battistoni, et al.
The Journal of Biological Chemistry|June 20, 2006
Huntingtin phosphorylation sites mapped by mass spectrometry. Modulation of cleavage and toxicityBirgit Schilling, Juliette Gafni, Cameron Torcassi, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Brain : a Journal of Neurology|January 24, 2026
Targeting UCHL3 attenuates pathological markers in neuronal models of Huntington's diseaseHasan Ishtayeh, Elena Battistoni, Sharon Pochtar, et al.
Journal of Neuroinflammation|March 8, 2024
TYROBP/DAP12 knockout in Huntington's disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deteriorationJordi Creus-Muncunill, Jean Vianney Haure-Mirande, Daniele Mattei, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 1996
Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the proteinT J Lyons, H Liu, J J Goto, et al.
Chemical Biology & Drug Design|August 3, 2006
Structural evaluation of a novel pro-apoptotic peptide coupled to CNGRC tumor homing sequence by NMRCristina M Sandoval, Bernhard H Geierstanger, Satoshi Fujimura, et al.
Neuron|July 31, 2010
Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's diseaseJohn P Miller, Jennifer Holcomb, Ismael Al-Ramahi, et al.
The Journal of Biological Chemistry|May 31, 2015
Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in VivoRobert O'Brien, Francesco DeGiacomo, Jennifer Holcomb, et al.
The Journal of Biological Chemistry|January 21, 2010
Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington diseaseChristian Landles, Kirupa Sathasivam, Andreas Weiss, et al.
Stem Cell Reports|December 15, 2015
Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem CellsKaren L Ring, Mahru C An, Ningzhe Zhang, et al.
Stem Cells (Dayton, Ohio)|May 8, 2025
Cerulenin Partially Corrects the Disrupted Developmental Transcriptomic Signature in Huntington's Disease Striatal Medium Spiny NeuronsCarlos Galicia Aguirre, Kizito-Tshitoko Tshilenge, Elena Battistoni, et al.
The Journal of Biological Chemistry|June 20, 2006
Huntingtin phosphorylation sites mapped by mass spectrometry. Modulation of cleavage and toxicityBirgit Schilling, Juliette Gafni, Cameron Torcassi, et al.
Pageof 13